
Expanding Test Menus: A Compliance Roadmap for FDA-Regulated Labs
Two OIG advisory opinions guide laboratories that want to work with pharma or medical device companies on expanded testing

Two OIG advisory opinions guide laboratories that want to work with pharma or medical device companies on expanded testing

Read this overview of legislation and regulations governing laboratory marketing practices and learn tips to ensure these activities remain compliant

Other recent legal actions include a self-disclosure settlement and punishment for alleged improper diagnostic test add-ons

The decision deepens a split among circuit courts regarding how to determine liability for false claims

Cases filed or resolved by the U.S. Department of Justice in the fourth quarter reveal the same compliance issues from early in 2024